A Phase II Study of SGN-30 in Combination with CHOP [cyclophosphamide + doxorubicin + vincristine + prednisone] in Anaplastic Large Cell Lymphoma.
Phase of Trial: Phase II
Latest Information Update: 16 Dec 2013
At a glance
- Drugs SGN 30 (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
- Indications Anaplastic large cell lymphoma; Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 15 Nov 2013 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 02 Jan 2013 Status changed from discontinued to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Oct 2012 Results published in a Millennium and Seattle Genetics media release.